Haim, N <br/><br/>
Dexamethasone, cytarabine, ifosfamide, and cisplatin as salvage therapy in non-Hodgkin lymphoma.  [electronic resource] 

 -  American journal of clinical oncology  Feb 1999 
 - 47-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-199902000-00012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Cytarabine--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Salvage Therapy<br/>Survival Analysis